Perspectives on Acquired Resistance to PD-1 Axis Inhibitors in Patients with Non-Small Cell Lung Cancer

J Thorac Oncol. 2018 Jun;13(6):741-744. doi: 10.1016/j.jtho.2018.04.008.

Authors

Diane Tseng¹, Sukhmani K Padda¹, Heather A Wakelee²

Affiliations

¹ Stanford Cancer Institute, Stanford University, Stanford, California.
² Stanford Cancer Institute, Stanford University, Stanford, California. Electronic address: hwakelee@stanford.edu.

PMID: 29793645
DOI: 10.1016/j.jtho.2018.04.008

No abstract available

Publication types

Editorial
Comment

MeSH terms

B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung*
Drug Resistance, Neoplasm
Humans
Lung Neoplasms*
Programmed Cell Death 1 Receptor

Substances

B7-H1 Antigen
Programmed Cell Death 1 Receptor